Chronic pelvic pain in men is associated with significant sexual dysfunction. Material and methods: Prospective study of 36 patients who underwent our given protocol comprising medical history, laboratory and physical examination. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) were used to document the severity/ frequency of pain, urinary and sexual symptoms. Subjective symptoms were scored by general assessment questions included loss of libido, quality of erection and pain on ejaculation too. Results: 36 patients with CP/CPPS 30 (83.3%) reported sexual dysfunction. NIH-CPSI total score with sexual dysfunction was (16-41) compared with (11-22) for patients without sexual dysfunction. At baseline 30 men with sexual dysfunction including only erectile dysfunction in 9 (30%), only ejaculatory difficulties in 9 (30%), both difficulties in 12 (40%), decreased libido in 24 (80%) and ejaculatory pain in 21 (70%). Patients reporting both erectile dysfunction and ejaculatory difficulty reported worse CP/CPPS symptoms than patients without sexual dysfunction. Conclusions: The impact of chronic pelvic pain syndrome on sexual function in men is underestimated. Men with erectile and ejaculatory dysfunction had more severe CPSI scores than men without such complaints. The presence of erectile and ejaculation dysfunction was related to significantly higher scores for domains of pain and quality of life. Sexual dysfunction merits consideration as an important aspect of CP/CPPS and potential outcome measure.
Evaluation of successfulness of new therapeutic strategy (biofeedback + praesacral nerves block) compared with still used treatment. Material and methods: Prospective study of 20 patients who were examined according to our given protocol: laboratory and urodynamic examinations (P/Q study), subjective evaluation of live quality and level symptoms severity-National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), duration period of symptoms. Urinary infection and bacterial prostatitis were exclusion criteria. Results: Medium term of follow up was (17 months, range 8–26). Duration period of symptoms was 1 year to 10 years. 3 patients (15%) were found to have obstructive voiding disorders according to P/Q study, that was further treated, equally 3 patients (15%) were found to have overactive bladder symptoms. 14 patients (70%) with normosenzitive stable detrusor praesacral nerves block + biofeedback was accomplished. 11 patients (78.57%) gave satisfactory effect, 3 patients (21.43%) gave no effect. Start of effect was between 1 day and 1 week, duration of effect was from 3 months to 6 months. There were no complications. Conclusions: Our given therapeutic strategy is miniinvasive method with medium-term up to long-term effect. Results showed, that patients with initial milder intensity (severity) of symptoms evaluate treatment effect favourably that is by low index than patients with longstanding, severe symptoms. Nowadays is obvious that urodynamic examination and NIH-CPSI will play the determinantal role as for separation of patients as for evaluation quality, severity and prognosis of disease. To identify treatments that might help prevent acute problems from becoming chronic, it will be the subject of continuation that study.
- MeSH
- lidé MeSH
- nemoci ledvin etiologie krev MeSH
- renální oběh MeSH
- žilní trombóza etiologie komplikace MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- kazuistiky MeSH
- MeSH
- erekce penisu MeSH
- lidé MeSH
- penis abnormality anatomie a histologie chirurgie MeSH
- ultrasonografie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- kazuistiky MeSH
Zdravotnické aktuality 123
1.vyd. 38 s.
